Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nu Holdings
NU
|
+$90.5M |
| 2 |
SW
Smurfit Westrock
SW
|
+$70M |
| 3 |
Pinduoduo
PDD
|
+$28.2M |
| 4 |
Microsoft
MSFT
|
+$24.7M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$21.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$118M |
| 2 |
Apple
AAPL
|
+$43.5M |
| 3 |
WRK
WestRock Company
WRK
|
+$38.2M |
| 4 |
Danaher
DHR
|
+$27.6M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.62% |
| 2 | Healthcare | 12.18% |
| 3 | Consumer Discretionary | 11.62% |
| 4 | Industrials | 9.21% |
| 5 | Communication Services | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Silicon Laboratories
SLAB
$7.28B
| $7.2M | ﹤0.01% |
62,300
-500
| -0.8% | -$55.8K |
|
1102
Gates Industrial Corporation Ltd.
GTES
$7B
| $7.16M | ﹤0.01% |
408,200
+18,500
| +5% | +$315K |
|
1103
Coty
COTY
$2.42B
| $7.16M | ﹤0.01% |
762,401
-30,000
| -4% | -$286K |
|
|
RNAM
1104
DELISTED
Avidity Biosciences
RNAM
| $7.15M | ﹤0.01% |
155,600
-800
| -0.5% | -$34.7K |
|
|
VRN
1105
DELISTED
Veren
VRN
| $7.13M | ﹤0.01% |
1,155,900
-13,800
| -1% | -$98.6K |
|
1106
National Health Investors
NHI
$3.5B
| $7.13M | ﹤0.01% |
84,820
-800
| -0.9% | -$61.7K |
|
1107
Hudbay
HBM
$11.8B
| $7.13M | ﹤0.01% |
773,800
-5,500
| -0.7% | -$44.3K |
|
1108
Plains GP Holdings
PAGP
$5.04B
| $7.12M | ﹤0.01% |
385,034
-2,000
| -0.5% | -$38K |
|
1109
Dutch Bros
BROS
$8.93B
| $7.12M | ﹤0.01% |
222,300
-1,500
| -0.7% | -$52.9K |
|
1110
Liberty Global Class C
LBTYK
$3.48B
| $7.12M | ﹤0.01% |
329,470
-9,200
| -3% | -$182K |
|
1111
Krystal Biotech
KRYS
$9.72B
| $7.12M | ﹤0.01% |
39,100
+2,900
| +8% | +$559K |
|
1112
Power Integrations
POWI
$3.48B
| $7.11M | ﹤0.01% |
110,900
-1,000
| -0.9% | -$66.1K |
|
1113
Valaris
VAL
$5.91B
| $7.1M | ﹤0.01% |
127,300
-900
| -0.7% | -$58.9K |
|
1114
Tanger
SKT
$4.42B
| $7.09M | ﹤0.01% |
213,600
-700
| -0.3% | -$20.4K |
|
1115
Hess Midstream
HESM
$5.11B
| $7.05M | ﹤0.01% |
200,000
+23,100
| +13% | +$847K |
|
1116
Steven Madden
SHOO
$3.46B
| $7.02M | ﹤0.01% |
143,325
+5,000
| +4% | +$222K |
|
|
GMS
1117
DELISTED
GMS Inc
GMS
| $7.01M | ﹤0.01% |
77,400
+2,900
| +4% | +$256K |
|
|
PCH
1118
DELISTED
PotlatchDeltic
PCH
| $7M | ﹤0.01% |
155,314
-1,300
| -0.8% | -$55K |
|
1119
Broadstone Net Lease
BNL
$4.35B
| $6.99M | ﹤0.01% |
369,100
| – | – |
|
1120
Prestige Consumer Healthcare
PBH
$2.43B
| $6.99M | ﹤0.01% |
97,000
-900
| -0.9% | -$63.7K |
|
1121
Perrigo
PRGO
$1.78B
| $6.99M | ﹤0.01% |
266,600
| – | – |
|
1122
Eldorado Gold
EGO
$10B
| $6.98M | ﹤0.01% |
401,120
-900
| -0.2% | -$15.1K |
|
1123
InterDigital
IDCC
$8.88B
| $6.98M | ﹤0.01% |
49,300
-900
| -2% | -$118K |
|
1124
Terex
TEX
$7.57B
| $6.97M | ﹤0.01% |
131,800
| – | – |
|
1125
Sweetgreen
SG
$721M
| $6.95M | ﹤0.01% |
196,100
-800
| -0.4% | -$24.3K |
|
Similar funds
Swiss National Bank's Q3 2024 Portfolio in Review
As of Q3 2024, Swiss National Bank held 2,510 positions worth $154B, up 5.8% from $146B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 3.9%. Swiss National Bank opened 52 new positions and exited 45, leaving the 2,510-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q3 2024 buy was Nu Holdings: 6,729,657 shares worth $91.9M.
- Swiss National Bank added most to Pinduoduo in Q3 2024, an estimated $28.2M increase.
- Swiss National Bank's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $118M.
- Swiss National Bank fully exited WestRock Company in Q3 2024, selling an estimated $38.2M.
- Swiss National Bank's ten largest holdings make up 32% of its $154B portfolio in Q3 2024.
- Swiss National Bank opened 52 new positions and closed 45 in Q3 2024.
- Swiss National Bank's portfolio value rose 5.8% quarter-over-quarter to $154B.
Based on Swiss National Bank's 13F filing for Q3 2024, filed 7 Nov 2024.